Warfarin induces cardiovascular damage in mice

Area of Science:

• Cardiovascular Research
• Vascular Biology
• Pharmacology

Background:

• Vascular calcification is a risk factor for cardiovascular disease.
• Matrix Gla protein and fetuin-A are key inhibitors of vascular calcification.
• Warfarin, a vitamin K antagonist, inactivates matrix Gla protein, impacting vascular health.

Purpose of the Study:

• To investigate the functional cardiovascular effects of warfarin-induced vascular calcification in a mouse model.
• To explore the role of vitamin K2 in mitigating warfarin's effects on vascular calcification.

Main Methods:

• DBA/2 mice were administered varying doses and durations of warfarin.
• Vitamin K1 and K2 treatments were administered concurrently with warfarin.
• Von Kossa staining assessed calcification; gene expression and apoptosis were analyzed.
• Functional cardiovascular parameters including aortic velocity and pulse-wave velocity were measured.

Main Results:

• Warfarin induced dose- and time-dependent calcification in the aorta and heart.
• Vitamin K2 treatment effectively inhibited warfarin-induced calcification.
• Warfarin increased apoptosis and reduced vascular smooth muscle cell numbers.
• Functional assessments showed augmented aortic peak velocity, aortic valve-peak gradient, and carotid pulse-wave velocity.

Conclusions:

• Warfarin causes significant vascular calcification and functional cardiovascular damage in mice.
• This study provides a model for investigating vascular calcification mechanisms.
• Findings may inform the development of novel therapeutic strategies for vascular calcification.